Q2 FY25 Highlights:• Revenue of $51.9 million, -6% vs prior corresponding period (pcp), +3% vs Q1 FY25o H1 FY25 revenue (excl. Google1) of $102.1 million, +2% vs pcp• Pleasing financial performance achieved in China business, reflected by Q2 FY25 revenue of $23.7 million, +77% vs pcp (H1 FY25 revenue of $42.2 million, +67% vs pcp);o Annualisedrevenuerun-rateexceeding$100millioninJune;ando FifthconsecutivequarterofstandaloneunderlyingEBITDA2profitability• Growth in China was offset by ongoing volatility and dynamic nature of the USAI market• Next phase of technology innovation and automation strategy with~$10 million annualised cost efficiencies identified in non-China businesso ~70%tobeexecutedbyendofQ3FY25,remainderbyendofQ4FY25• Healthy cash balance remains with cash on hand as at 30 June 2025 of $60.9million• FY25 revenue guidance: tracking towards low end of $235 million to $260 million range
APX Price at posting:
$1.10 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Q2 FY25 revenue of $23.7 million, +77% vs pcp (H1 FY25 revenue of $42.2 million, +67% vs pcp);o Annualisedrevenuerun-rateexceeding$100millioninJune;ando FifthconsecutivequarterofstandaloneunderlyingEBITDA2profitability• Growth in China was offset by ongoing volatility and dynamic nature of the USAI market• Next phase of technology innovation and automation strategy with~$10 million annualised cost efficiencies identified in non-China businesso ~70%tobeexecutedbyendofQ3FY25,remainderbyendofQ4FY25• Healthy cash balance remains with cash on hand as at 30 June 2025 of $60.9million• FY25 revenue guidance: tracking towards low end of $235 million to $260 million range
(20min delay)